10554-64-0 Usage
Description
2-(2,3-Dihydro-1,4-benzodioxin-6-yl)ethanamine hydrochloride, commonly known as 6-APDB, is a research chemical belonging to the amphetamine class. It is a psychoactive substance with both psychedelic and stimulant effects, primarily used in scientific research to explore its potential therapeutic properties. As a selective serotonin releasing agent (SSRA), 6-APDB increases serotonin levels in the brain, resulting in mood enhancement and feelings of empathy. Additionally, it is known to produce hallucinogenic effects, contributing to its popularity in the underground recreational drug scene. However, due to limited research and potential health risks, it is not approved for medical use and is considered a controlled substance in many countries.
Uses
Used in Scientific Research:
6-APDB is used as a research chemical for investigating its potential therapeutic properties and understanding its mechanism of action as a selective serotonin releasing agent (SSRA). This research aims to explore its effects on mood enhancement, empathy, and serotonin levels in the brain.
Used in Psychopharmacology Studies:
In the field of psychopharmacology, 6-APDB is utilized to study its psychedelic and stimulant effects, as well as its potential applications in the treatment of various mental health disorders. The hallucinogenic properties of 6-APDB make it a subject of interest for researchers seeking to understand the underlying neurochemical processes associated with these effects.
Used in Controlled Substance Regulation:
Due to its limited research, potential health risks, and popularity in the underground recreational drug scene, 6-APDB is considered a controlled substance in many countries. Its use is regulated to prevent misuse and ensure that any potential therapeutic applications are thoroughly investigated and approved for medical use.
Check Digit Verification of cas no
The CAS Registry Mumber 10554-64-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,0,5,5 and 4 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 10554-64:
(7*1)+(6*0)+(5*5)+(4*5)+(3*4)+(2*6)+(1*4)=80
80 % 10 = 0
So 10554-64-0 is a valid CAS Registry Number.
InChI:InChI=1/C10H13NO2/c11-4-3-8-1-2-9-10(7-8)13-6-5-12-9/h1-2,7H,3-6,11H2
10554-64-0Relevant articles and documents
COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING NASH, NAFLD, AND OBESITY
-
, (2021/04/10)
The present technology relates to methods of treating NASH, NAFLD and/or obesity using compounds of Formulas I, II, III, IV, V, and/or VI. The methods include administering to a subject suffering from one or more of non-alcoholic steatohepatitis (NASH), non- alcoholic fatty liver disease (NAFLD) and/or obesity a therapeutically effective amount of such a compound
PYRIMIDINE DERIVATIVES AS PGE2 RECEPTOR MODULATORS
-
Page/Page column 94; 131, (2018/12/13)
The present invention relates to pyrimidine derivatives of formula (I) wherein (R1)n, R3, R4a, R4b, R5a, R5b and Ar1 are as described in the description and their use in the treatment of cancer by modulating an immune response comprising a reactivation of the immune system in the tumor. The invention further relates to novel benzofurane and benzothiophene derivatives of formula (II) and their use as pharmaceuticals, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), and especially to their use as modulators of the prostaglandin 2 receptors EP2 and/or EP4.
Compounds and Compositions for Modulating Lipid Levels and Methods of Preparing Same
-
Page/Page column 43, (2011/02/15)
The present technology relates to compounds of Formulas I-VI and methods of making and using such compounds. Methods of use include prevention and treatment of hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, hepatic steatosis, and metabolic syndrome. Compounds disclosed herein also increase HDL-C, lower total cholesterol, LDL-cholesterol, and triglycerides and increase hepatic LDL receptor expression, inhibit PCSK9 expression, and activate AMP-activated protein kinase.
